Real-World Data on GLP-1 Agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the therapeutic landscape for type 2 diabetes mellitus (T2DM) and obesity. These agents mimic endogenous GLP-1, which enhances glucose-dependent insulin secretion, delays gastric…